1. Influence of cytogenetics in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone: adverse effect of deletion 17p13
by Donna Reece, Kevin W. Song, Tommy Fu, Birgitte Roland, Hong Chang, Douglas E. Horsman, Adnan Mansoor, Christine Chen, Esther Masih-Khan, Young Trieu, Helene Bruyere, Douglas A. Stewart, and Nizar J. Bahlis
Blood
Volume 114(3):
July 16, 2009
©2009 by American Society of Hematology

2. Kaplan-Meier curves for TTP and OS in the cytogenetic abnormality groups.
Kaplan-Meier curves for TTP and OS in the cytogenetic abnormality groups. The vertical axis represents the percentage of patients with disease progression (A,C,E,G) or the percentage of patients surviving (B,D,F,H). (A-B) TTP and OS for patients with or without del(13q). (C-D) TTP and OS for patients with or without t(4;14). (E-F) TTP and OS for patients with or without del(17p13). (G-H) TTP and OS for patients with or without t(4;14) matched pairs. CI indicates confidence interval; and HR, hazard ratio.
Donna Reece et al. Blood 2009;114:
©2009 by American Society of Hematology